ISRN DermatologyPub Date : 2011-01-01Epub Date: 2011-05-18DOI: 10.5402/2011/549870
Nathalie Hirt-Burri, Albert-Adrien Ramelet, Wassim Raffoul, Anthony de Buys Roessingh, Corinne Scaletta, Dominique Pioletti, Lee Ann Applegate
{"title":"Biologicals and fetal cell therapy for wound and scar management.","authors":"Nathalie Hirt-Burri, Albert-Adrien Ramelet, Wassim Raffoul, Anthony de Buys Roessingh, Corinne Scaletta, Dominique Pioletti, Lee Ann Applegate","doi":"10.5402/2011/549870","DOIUrl":"10.5402/2011/549870","url":null,"abstract":"<p><p>Few biopharmaceutical preparations developed from biologicals are available for tissue regeneration and scar management. When developing biological treatments with cellular therapy, selection of cell types and establishment of consistent cell banks are crucial steps in whole-cell bioprocessing. Various cell types have been used in treatment of wounds to reduce scar to date including autolog and allogenic skin cells, platelets, placenta, and amniotic extracts. Experience with fetal cells show that they may provide an interesting cell choice due to facility of outscaling and known properties for wound healing without scar. Differential gene profiling has helped to point to potential indicators of repair which include cell adhesion, extracellular matrix, cytokines, growth factors, and development. Safety has been evidenced in Phase I and II clinical fetal cell use for burn and wound treatments with different cell delivery systems. We present herein that fetal cells present technical and therapeutic advantages compared to other cell types for effective cell-based therapy for wound and scar management.</p>","PeriodicalId":14682,"journal":{"name":"ISRN Dermatology","volume":"2011 ","pages":"549870"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30484041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ISRN DermatologyPub Date : 2011-01-01Epub Date: 2011-05-31DOI: 10.5402/2011/809409
Goran Jeremic, Corey C Moore, Michael G Brandt, Philip C Doyle
{"title":"Neoadjuvant use of photodynamic therapy in Basal cell and squamous cell carcinomas of the face.","authors":"Goran Jeremic, Corey C Moore, Michael G Brandt, Philip C Doyle","doi":"10.5402/2011/809409","DOIUrl":"10.5402/2011/809409","url":null,"abstract":"<p><p>Background. This preliminary study sought to determine the success of photodynamic therapy (PDT) in reducing lesion size in an effort to assess the potential application of this treatment approach in a neoadjuvant role. Objectives. To quantify the effects of PDT on lesion area (mm(2)) for basal cell and squamous cell carcinomas of the face. Results. Eighteen participants (10 BCC lesions and 8 SCC lesions of the face) were assessed. Four lesions (all from the BCC group) showed a complete response to PDT. Of the remaining 14 lesions, 85.7% (n = 12) showed reductions in lesion area, while two lesions showed increase in lesion area. Proportional reductions for the 12 lesions that did not demonstrate complete response or an increase in area following-PDT were found to range from 13.2% to 85.1% (BCC) and 6.7% to 89.7% (SCC). Conclusions. PDT as a neoadjuvant treatment may provide a simple, efficient, and viable approach to reducing the area of malignant lesions of the face with the advantage of reduced cosmetic and aesthetic morbidities.</p>","PeriodicalId":14682,"journal":{"name":"ISRN Dermatology","volume":"2011 ","pages":"809409"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262545/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30484719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ISRN DermatologyPub Date : 2011-01-01Epub Date: 2011-04-05DOI: 10.5402/2011/813513
Andrew L Ross, Margaret I Sanchez, James M Grichnik
{"title":"Nevogenesis: a benign metastatic process?","authors":"Andrew L Ross, Margaret I Sanchez, James M Grichnik","doi":"10.5402/2011/813513","DOIUrl":"https://doi.org/10.5402/2011/813513","url":null,"abstract":"<p><p>It is generally accepted that cutaneous nevogenesis is a localized event that occurs exclusively in the dermis and/or epidermis. However, the discovery of nevocytes circulating in the peripheral blood suggests that other, more systemic, benign metastatic processes could also be involved. The theoretical role of lymphatic and hematogenous dissemination of loosely adherent, immature nevus progenitor cells in the development of nodal nevi and eruptive melanocytic nevi will be reviewed.</p>","PeriodicalId":14682,"journal":{"name":"ISRN Dermatology","volume":"2011 ","pages":"813513"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/813513","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30484720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ISRN DermatologyPub Date : 2011-01-01Epub Date: 2011-09-05DOI: 10.5402/2011/150642
A Raz-Pasteur, Y Ullmann, I Berdicevsky
{"title":"The pathogenesis of Candida infections in a human skin model: scanning electron microscope observations.","authors":"A Raz-Pasteur, Y Ullmann, I Berdicevsky","doi":"10.5402/2011/150642","DOIUrl":"https://doi.org/10.5402/2011/150642","url":null,"abstract":"<p><p>Cutaneous candidiasis is an opportunistic infection that arises, in most cases, from endogenous, saprophytic candidal blastospores that selectively colonize oral, gastrointestinal, vaginal, and cutaneous epithelium. Candida albicans has been regarded as the most common causative agent in human fungal infections. However, other Candida species have become a significant cause of infection. Scanning electron microscope (SEM) observations were used to analyze the capability of C. albicans, C. tropicalis, and C. parapsilosis to adhere to human skin model, used in this study, which was found to mimic the human skin in vivo. The skin sections were inoculated with low and high concentration of the yeasts and followed for 1 and 5 days; then they were viewed by SEM. The electron microscopy observations revealed that all three yeasts tested adhered to the skin but C. albicans covered the entire skin model to a higher extent than C. tropicalis or C. parapsilosis. Mucin-like material coated the blastoconidia mainly in C. albicans. All Candida species have shown characteristics resembling biofilm formation. The use of human skin sections for ex vivo evaluation of adherence of various yeasts may partially explain the predominance of C. albicans in cutaneous pathogenicity.</p>","PeriodicalId":14682,"journal":{"name":"ISRN Dermatology","volume":"2011 ","pages":"150642"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262537/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30485156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ISRN DermatologyPub Date : 2011-01-01Epub Date: 2011-03-15DOI: 10.5402/2011/342909
Naveed Natanzi, David Peng, Eli Ahdoot, Sandra Ghatan, Amy Reinstandler, Ramin Ram
{"title":"Xanthoma disseminatum in a pair of blind, deaf male twins.","authors":"Naveed Natanzi, David Peng, Eli Ahdoot, Sandra Ghatan, Amy Reinstandler, Ramin Ram","doi":"10.5402/2011/342909","DOIUrl":"10.5402/2011/342909","url":null,"abstract":"<p><p>Xanthoma disseminatum (XD) is a rare normolipemic histiocytic disorder of non-Langerhans cell origin characterized by erythematous to tan/brown papules in flexor surfaces. Considered a generally benign, chronic disease of unknown etiology, XD typically affects the skin, mucous membranes, and less commonly, other organs. To date, there has been no typical or consistent inheritance pattern described, nor has it ever been considered as a component of any known syndrome. We describe, for the first time, two cases of XD in a pair of blind and deaf twin brothers.</p>","PeriodicalId":14682,"journal":{"name":"ISRN Dermatology","volume":"2011 ","pages":"342909"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/342909","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30485160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ISRN DermatologyPub Date : 2011-01-01Epub Date: 2011-06-22DOI: 10.5402/2011/642157
Andrew L Ross, Margaret I Sanchez, James M Grichnik
{"title":"Nevus senescence.","authors":"Andrew L Ross, Margaret I Sanchez, James M Grichnik","doi":"10.5402/2011/642157","DOIUrl":"10.5402/2011/642157","url":null,"abstract":"<p><p>Melanomas and nevi share many of the same growth-promoting mutations. However, melanomas grow relentlessly while benign nevi eventually undergo growth arrest and stabilize. The difference in their long-term growth potential may be attributed to activation of cellular senescence pathways. The primary mediator of senescence in nevi appears to be p16. Redundant, secondary senescence systems are also present and include the p14-p53-p21 pathway, the IGFBP7 pathway, the FBXO31 pathway, and the PI3K mediated stress induced endoplasmic reticulum unfolded protein response. It is evident that these senescence pathways result in an irreversible arrest in most instances; however, they can clearly be overcome in melanoma. Circumvention of these pathways is most frequently associated with gene deletion or transcriptional repression. Reactivation of senescence mechanisms could serve to inhibit melanoma tumor progression.</p>","PeriodicalId":14682,"journal":{"name":"ISRN Dermatology","volume":"2011 ","pages":"642157"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30484043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ISRN DermatologyPub Date : 2011-01-01Epub Date: 2011-03-31DOI: 10.5402/2011/704549
O Hocar, H Yacoubi, N Akhdari, S Amal, F Ait Essi, M Latifi, H Rais, B Belaabidia
{"title":"Unusual presentation of a rare tumor of the dorsal surface of the foot.","authors":"O Hocar, H Yacoubi, N Akhdari, S Amal, F Ait Essi, M Latifi, H Rais, B Belaabidia","doi":"10.5402/2011/704549","DOIUrl":"https://doi.org/10.5402/2011/704549","url":null,"abstract":"<p><p>Calcifying aponeurotic fibroma (CAF) was originally described by Keasbey in 1953 as juvenile aponeurotic fibroma, most commonly occurring in the palms of the hands and soles of the feet in children and adolescents. It usually presents as a firm, painless mass without preceding trauma. We report a case of this rare condition with an unusual presentation in a 60-year-old woman affecting the dorsal surface of the foot. It is a relatively benign condition with a good prognosis following complete surgical excision. It may have a slightly increased incidence in males. The accurate diagnosis is based only on histology but it is essential to differentiate it from other sinister lesions such as fibrosarcoma that may lead to amputation.</p>","PeriodicalId":14682,"journal":{"name":"ISRN Dermatology","volume":"2011 ","pages":"704549"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/704549","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30484045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ISRN DermatologyPub Date : 2011-01-01Epub Date: 2011-04-10DOI: 10.5402/2011/848909
Rancés Blanco, Enrique Rengifo, Charles E Rengifo, Mercedes Cedeño, Milagros Frómeta, Adriana Carr
{"title":"Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms.","authors":"Rancés Blanco, Enrique Rengifo, Charles E Rengifo, Mercedes Cedeño, Milagros Frómeta, Adriana Carr","doi":"10.5402/2011/848909","DOIUrl":"https://doi.org/10.5402/2011/848909","url":null,"abstract":"<p><p>The evaluation of 14F7 Mab (anti-N-glycolyl GM3 ganglioside) immunorecognition in normal skin, cutaneous malignant melanoma (CMM), and in lymph node metastases (LNM) has been previously reported. In this work we extended the study to benign (BMN) and dysplastic (DMN) melanocytic nevi, basal (BCC), and squamous cell carcinoma (SCC). Immunohistochemical assays with 14F7 followed by a biotinylated link universal and streptavidin-AP in normal and pathological tissues were made. No reaction of 14F7 in normal skin (0/10) as well as a low reactivity in BMN (2/11) and DMN (1/7) was detected. A limited staining in BCC (2/13) and in SCC (4/8) was also evidenced, while 14F7 Mab were mostly reactive in CMM (28/28) and in LNM (6/7). These results suggest that 14F7 reactivity could be closely related with the more aggressive biological behavior of CMM and also support the use of NeuGcGM3 as target for both passive and active melanoma immunotherapy.</p>","PeriodicalId":14682,"journal":{"name":"ISRN Dermatology","volume":"2011 ","pages":"848909"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/848909","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30484722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ISRN DermatologyPub Date : 2011-01-01Epub Date: 2011-06-07DOI: 10.5402/2011/947284
Waka Ishida, Teruhiko Makino, Tadamichi Shimizu
{"title":"Severe Hair Loss of the Scalp due to a Hair Dye Containing Para phenylenediamine.","authors":"Waka Ishida, Teruhiko Makino, Tadamichi Shimizu","doi":"10.5402/2011/947284","DOIUrl":"https://doi.org/10.5402/2011/947284","url":null,"abstract":"<p><p>We report the case of a 41-year-old female showing severe hair loss approximately 90% after the use of a hair dye. These symptoms developed six days after the use of a hair dye containing PPD. A patch test showed a (++) reaction at 48 h to 1% PPD in petrolatum, whereas all metals and white petrolatum were negative. She was therefore diagnosed with contact dermatitis due to PPD, resulting in hair loss. The skin lesions gradually improved after starting treatment with the systemic corticosteroids. The possibility that allergic contact dermatitis from hair dyes may be responsible for telogen effluvium should always be considered in a patient with increased hair loss.</p>","PeriodicalId":14682,"journal":{"name":"ISRN Dermatology","volume":"2011 ","pages":"947284"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/947284","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30484723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ISRN DermatologyPub Date : 2011-01-01Epub Date: 2011-04-11DOI: 10.5402/2011/241953
A W Rafi, R M Katz
{"title":"Pilot Study of 15 Patients Receiving a New Treatment Regimen for Androgenic Alopecia: The Effects of Atopy on AGA.","authors":"A W Rafi, R M Katz","doi":"10.5402/2011/241953","DOIUrl":"https://doi.org/10.5402/2011/241953","url":null,"abstract":"<p><p>Background. We examined the efficacy of a new regimen to treat AGA, with attention to male patients who are atopic. Objective. To assess the efficacy of a four-part regimen for the treatment of AGA in atopic and nonatopic patients. NuH Hair is a novel topical combination of finasteride, dutasteride, and minoxidil, which is blended in a hypoallergenic lotion. The other three components included Rogaine foam, Propecia, and ketoconazole shampoo. Methods. A prospective pilot study was conducted in 15 patients. All patients were assessed for the presence of atopy. Each patient served as their own control. All patients were treated specifically with NuH Hair and were given the option to add any of the other components of the protocol to their regimen. Photographs were taken of each patient's scalp at months 0, 1, 3, 6, and 9. Results. All 15 patients demonstrated significant growth of hair. In those patients who utilized all 4 components, significant growth was achieved in as little as 30 days. In those patients who choose only to utilize NuH Hair, significant growth was demonstrated after 3 months. Conclusion. Aggressively treating AGA achieves significant and rapid growth of new hair. This is effective in atopic and nonatopic male patients.</p>","PeriodicalId":14682,"journal":{"name":"ISRN Dermatology","volume":"2011 ","pages":"241953"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2011/241953","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30485158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}